Epic Research Update : Ipca Laboratories

Ipca Laboratories is expecting overall growth for FY14 and FY15 to be around 18-20%. Out of 18 products the company is currently able to supply only 8 products to the US due to capacity constraints. But now with expansion of capacity at the Indore facility, all the products have been taken in for commercialization, and the full utilization will take place over two years. The company is also looking at further expansion of capacity at Indore.

For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI

Posted in: Indian Market Tips